Corneal Topography in Vernal Keratoconjunctivitis

NCT06746467 · tracked via the Priya Life Science Egypt tracker

Sponsor

Assiut University

Phase

Observational

Started

2025-06

Last updated

2024-12-24

Condition(s) studied

Keratoconjunctivitis

Investigational drug(s) / intervention(s)

pentacam

pentacam: evaluate corneal changes by pentacam

Study summary

To evaluate the corneal topographic changes in VKC patients using Pentacam and prevalence of KC development in VKC.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: clinical diagnosis of vernal keratoconjunctivitis - Exclusion Criteria: patients with corneal disease as corneal opacity, corneal dystrophy or degenerative changes patients with previous corneal surgery patients with ocular trauma. \-

Primary outcome measure(s)

evaluate the corneal topographic changes in VKC patients using Pentacam — 1 year

Trial sites (1)

Facility	City	Region	Status
Assiut University	Asyut	Egypt

More Assiut University trials in Egypt

Prognostic Value of the LVOT VTI in STEMI Patients Undergoing PPCI Starting soon

Prevalence of Sarcopenia and Its Associated Factors in Patients With Knee Osteoarthritis in a Tertiary Care Hospital in Upper Egypt Starting soon

Oucomes of Endovascular Atherectomy in Femoropopliteal Arterial Disease Active, not recruiting

Serum Talin-1 and Cripto-1 in Colorectal Cancer Starting soon

Role of Oral Care in Prevention of Nosocomial Pneumonia Among COPD Patients Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06746467 on ClinicalTrials.gov ↗ ← All trials in Egypt